Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 308M | 231M | 192M | 159M | 113M | 77M |
| Cost of revenue | 73M | 55M | 46M | 40M | 25M | 17M |
| Gross profit | 235M | 176M | 146M | 119M | 88M | 60M |
| Research and development | 126M | 79M | 67M | 65M | 51M | 40M |
| Selling, general and administrative | 26M | 22M | 20M | 22M | 23M | 22M |
| Operating expenses | 173M | 120M | 106M | 108M | 97M | 84M |
| Operating income | 62M | 55M | 40M | 11M | −9M | −24M |
| Pre-tax income | 73M | 67M | 51M | 22M | 2M | −14M |
| Income tax | −7M | −24M | −560,000 | −10M | 10M | −7M |
| Net income | 80M | 91M | 51M | 32M | −8M | −8M |
| Earnings per share | 0.47 | 0.54 | 0.31 | 0.19 | −0.05 | −0.05 |
| Earnings per share, diluted | 0.44 | 0.50 | 0.29 | 0.18 | −0.05 | −0.05 |
| Weighted average shares | 171M | 167M | 165M | 163M | 157M | 155M |
| Weighted average shares, diluted | 181M | 181M | 178M | 178M | 157M | 155M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 148M | 168M | 140M | 162M | 86M | 80M | 126M | 421M |
| Receivables | 135M | 83M | 43M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 75M | — | — | 11M | — | — |
| Depreciation and amortisation | 4M | 2M | 1M | 1M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 24M |
| 70M |
| 39M |
| 25M |
| 22M |
| Inventory | 60M | 59M | 52M | 59M | 51M | 43M | 24M | 29M |
| Current assets | 1.41B | 1.36B | 1.29B | 1.18B | 1.08B | 1.01B | 946M | 891M |
| Property, plant and equipment | 97M | 92M | 72M | 62M | 39M | 36M | 35M | 22M |
| Goodwill | 88M | 19M | — | — | — | — | — | — |
| Total assets | 1.66B | 1.53B | 1.40B | 1.27B | 1.12B | 1.05B | 983M | 916M |
| Current liabilities | 125M | 133M | 101M | 106M | 77M | 87M | 88M | 64M |
| Total liabilities | 165M | 168M | 129M | 136M | 80M | 90M | 93M | 70M |
| Equity | 1.49B | 1.36B | 1.27B | 1.14B | 1.04B | 965M | 890M | 845M |
| Shares outstanding | 171M | 170M | 169M | 166M | 165M | 162M | 159M | 157M |
| Shares issued | 171M | 170M | 169M | 166M | 165M | 162M | 159M | 157M |
| 800,000 |
| 700,000 |
| Share-based compensation | 49M | — | — | 42M | — | — |
| Capital expenditure | 8M | — | — | 5M | — | — |
| Investing cash flow | −94M | — | — | −4M | — | — |
| Financing cash flow | 82,000 | — | — | 386,000 | — | — |